BRIEF-Lexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA Therapeutics

Reuters
24 Jun
BRIEF-<a href="https://laohu8.com/S/LXEO">Lexeo Therapeutics</a>, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA <a href="https://laohu8.com/S/LENZ">Therapeutics</a>

June 24 (Reuters) - Lexeo Therapeutics Inc LXEO.O:

  • LEXEO THERAPEUTICS, PERCEPTIVE XONTOGENY VENTURE FUNDS AND VENBIO PARTNERS ANNOUNCE PARTNERSHIP TO ADVANCE NOVEL CARDIAC RNA THERAPEUTICS

  • LEXEO THERAPEUTICS INC: INVESTMENT OF UP TO $40 MILLION FROM PERCEPTIVE XONTOGENY VENTURE FUNDS AND VENBIO PARTNERS

Source text: ID:nGNX8td1pG

Further company coverage: LXEO.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10